SebitChem Co., Ltd.

As of June 30, 2026, SebitChem Co., Ltd. carries a market capitalization of 85.30B, placing it among publicly traded companies globally. Its enterprise value stands at 102.60B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

SebitChem Co., Ltd.'s next confirmed earnings release is scheduled for November 12, 2026.

As of June 30, 2026, SebitChem Co., Ltd. has 5.63M shares outstanding.

These figures are as of June 30, 2026. The price-to-sales ratio is 1.76, and the price-to-book ratio stands at 1.85.

These figures are as of June 30, 2026. The EV/Sales ratio of 2.11 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. These enterprise value multiples are built on an enterprise value of 102.60B versus a market cap of 85.30B, with the gap driven by net debt and cash on the balance sheet.

As of June 30, 2026, SebitChem Co., Ltd. maintains a current ratio of 3.14, meaning it holds 3.1x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 77.47, indicating elevated leverage, while an interest coverage ratio of -1.01 demonstrates limited ability to service its debt obligations.

Over the twelve months ended June 30, 2026, SebitChem Co., Ltd. posted a negative return on equity (ROE) of -24.74, meaning shareholder capital produced losses rather than profits. Return on assets (ROA) is negative at -13.97, reflecting losses generated across the asset base. The company generates approximately 384.50M in revenue per employee across its workforce of 126.25, a quick read on workforce productivity versus industry peers. Inventory turnover of 9.96 indicates how many times SebitChem Co., Ltd. sells and replaces its inventory over a year, a key working capital efficiency ratio.

Over the twelve months ended June 30, 2026, SebitChem Co., Ltd. recorded 67.30M in income tax expense. The company reported a pretax loss of -7.80B and -12.90B in bottom-line net income, so the effective tax rate carries little signal until profitability returns.

As of the close on October 23, 2026, SebitChem Co., Ltd.'s stock has declined approximately 69.97% over the past 52 weeks. The 50-day moving average sits at 14,306.00, while the 200-day moving average is 22,072.65.

Over the twelve months ended June 30, 2026, SebitChem Co., Ltd. generated 48.54B in revenue and converted that into -12.90B in net income, yielding earnings per share of -2,287.63. EBITDA reached -1.36B, while operating income came in at -5.26B.

As of June 30, 2026, SebitChem Co., Ltd. holds 18.93B in cash and equivalents against 35.94B in total debt, resulting in a net debt position of 21.01B. Total book value stands at 46.11B, with working capital of 22.26B providing operational flexibility.

SebitChem Co., Ltd. produced -5.15B in operating cash flow over the twelve months ended June 30, 2026. After subtracting -884.88M in capital expenditures, free cash flow totaled -6.04B - equivalent to -1,071.88 per share.

Over the twelve months ended June 30, 2026, SebitChem Co., Ltd. posted a gross margin of 4.79, reflecting its pricing power and cost economics. The operating margin of -10.83 and net profit margin of -26.58 provide insight into operational efficiency.

These figures cover the twelve months ended June 30, 2026. Free cash flow yield is negative at -7.06: the business is consuming cash rather than generating it, so any dividend is not covered by free cash flow. Total shareholder yield reaches 2.00, combining dividends paid with share buybacks and debt reduction for a fuller picture of capital returned to SebitChem Co., Ltd. shareholders.

As of June 30, 2026, SebitChem Co., Ltd. has an Altman Z-Score of 1.79, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.